Join us on the 24th March 2026 for the Lung Cancer Study Day. This event is Hybrid
Overview
This multidisciplinary educational event brings together renowned healthcare professionals to explore the rapidly evolving landscape of lung cancer management. As one of the most prevalent malignancies, lung cancer presents complex challenges requiring coordinated care across multiple specialities and innovative approaches to diagnosis, treatment, and survivorship.
Our study day addresses critical developments in diagnosis, emerging therapeutic strategies, and patient-centred care approaches that are transforming outcomes for patients.
Intended Audience
Oncologists, Respiratory Physicians, Thoracic Surgeons, Specialist Nurses, Radiologists, Pathologists, Allied Health Professionals, and all healthcare professionals involved in lung cancer care
What to expect
- Lung cancer management, including screening, toxicity management and non-pharmacological approaches to challenging lung cancer symptoms.
- Evolving treatment landscapes for NSCLC & SCLC
- Current research studies, clinical trials, and emerging treatments.
Join Your Colleagues:
- In-person: Education Centre, The Christie (easy access via local transport links)
- Virtual: Participate from your workplace
- Catch-up access: 6-month replay available – perfect for busy clinical schedules
Agenda
To be confirmed
